Aorto Femoral Bypass Graft in Chronic Limb Ischemia Patient
Versions
- 2021-03-30 (2)
- 2021-03-27 (1)
Downloads
Conte M S, Pomposelli F B, Clair D G, Geraghty P J, McKinsey J F, et al. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and claudication J. Vasc. Surg. 2015.
Antoniou G A, Georgiadis G S, Antoniou S A, Makar R R, Smout J D and Torella F. Bypass surgery for chronic lower limb ischaemia Cochrane Database Syst. Rev. 2017.
Aboyans V, Ricco J B, Bartelink M L E L, Björck M, Brodmann M, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS) Eur. Heart J. 2018.
Norgren L, Hiatt W R, Bell K, Nehler M R, Harris K A, Fowkes F G R, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) Eur. J. Vasc. Endovasc. Surg. 2007.
Anon 2017 Correction. AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines (Journal of the American J. Am. Coll. Cardiol. 2016.
Oresanya L, Zhao S, Gan S, Fries B E, Goodney P P, et al. Functional outcomes after lower extremity revascularization in nursing home residents: A national cohort study JAMA Intern. Med. 2015;175 951–7.
Kinlay S. US Department of Veterans Affairs Circ Cardiovasc Interv. 2017; 9: 1–23.
Todd D J, Kagan A, Chibnik L B and Kay J. Cutaneous changes of nephrogenic systemic fibrosis: Predictor of early mortality and association with gadolinium exposure Arthritis Rheum. 2007.; 56: 3433–41.
Thukkani A K, and Kinlay S. Endovascular Intervention for Peripheral Artery Disease Circ. Res. 2015.; 116: 1599–613.
AbuRahma A F, Hayes J D, Flaherty S K and Peery W. Primary iliac stenting versus transluminal angioplasty with selective stenting J. Vasc. Surg. 2007. 46.
Slovut D P, and Lipsitz E C. Surgical technique and peripheral artery disease Circulation. 2012; 126: 1127–38.
Rosenfield K, Jaff M R, White C J, Rocha-Singh K, Mena-Hurtado C, et al. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease N. Engl. J. Med. 2015;373: 145–53.
Krankenberg H, Tübler T, Ingwersen M, Schlüter M, Scheinert D, et al. Drug-coated balloon versus standard balloon for superficial femoral artery in-stent restenosis: The randomized Femoral Artery In-Stent Restenosis (FAIR) trial Circulation. 2015; 132: 2230–6.
Sharma G, Scully R E, Shah S K, Madenci A L, Arnaoutakis D J, et al. Thirty-year trends in aortofemoral bypass for aortoiliac occlusive disease J. Vasc. Surg. 2018.
Ameli F M, Provan J L, Williamson C and Keuchler P M. Etiology and management of aorto-femoral bypass graft failure. J. Cardiovasc. Surg. (Torino). 1987.
Conte M S. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) and the (hoped for) dawn of evidence-based treatment for advanced limb ischemia J. Vasc. Surg. 2010;51: 69S-75S.
Li Z, Feng R, Qin F, Zhao Z, Yuan L, et al. Recanalization of native superficial femoral artery chronic total occlusion after failed femoropopliteal bypass in patients with critical limb ischemia J. Interv. Cardiol. 2018.
Taylor S M, Kalbaugh C A, Blackhurst D W, Hamontree S E, Cull D L, et al. Preoperative clinical factors predict postoperative functional outcomes after major lower limb amputation: An analysis of 553 consecutive patients J. Vasc. Surg. 2005;42:227–34.
Mills J L, Conte M S, Armstrong D G, Pomposelli F B, Schanzer A and Sidawy A N. The Society for Vascular Surgery Lower Extremity Threatened Limb Classi fi cation System : Risk strati fi cation based on Wound , Ischemia , and foot Infection ( WIfI ) J. Vasc. Surg. 1982;59:220-234e2.
Copyright (c) 2021 R. Muhammad Budiarto, MD, M. Rifqi D. Hasan
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
- Cardiovascular and Cardiometabolic Journal (CCJ) is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License
-
Authors who publish with Cardiovascular and Cardiometabolic Journal (CCJ) agree to the following terms:
-
The journal allows the author to hold the copyright of the article without restrictions.
-
The journal allows the author(s) to retain publishing rights without restrictions.
-
The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution ShareAlike 4.0 International License (CC BY-SA).
